TWD 42.0
(6.06%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -325.51 Million TWD | -16.31% |
2022 | -290.07 Million TWD | -57.35% |
2021 | -177.85 Million TWD | -340715.13% |
2020 | 52.21 Thousand TWD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -115.76 Million TWD | -2.77% |
2024 Q1 | -112.65 Million TWD | -6.05% |
2023 Q4 | -106.22 Million TWD | 0.0% |
2023 FY | - TWD | -16.31% |
2023 Q3 | -106.22 Million TWD | -72.11% |
2023 Q2 | -61.71 Million TWD | 0.0% |
2023 Q1 | -61.71 Million TWD | 4.28% |
2022 FY | - TWD | -57.35% |
2022 Q4 | -64.47 Million TWD | 0.0% |
2022 Q3 | -64.47 Million TWD | 0.0% |
2021 FY | - TWD | -340715.13% |
2020 FY | - TWD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 182.7% |
Level Biotechnology Inc. | 98.7 Million TWD | 429.787% |
Sagittarius Life Science Corp | -44.73 Million TWD | -627.582% |
NeoCore Technology Co., Ltd. | -72.11 Million TWD | -351.38% |
TaiMed Biologics Inc. | -25.23 Million TWD | -1190.029% |
GlycoNex Incorporation | -126.82 Million TWD | -156.659% |
VBI | -6.97 Million TWD | -4568.861% |
GeneReach Biotechnology Corp. | -143.69 Million TWD | -126.53% |
Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 1592.494% |
Visgeneer Inc. | 973 Thousand TWD | 33554.573% |
Mycenax Biotech Inc. | -339.48 Million TWD | 4.115% |
Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 134.76% |
G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 426.044% |
Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 67.156% |
TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -18639.954% |
Enimmune corporation | -228.96 Million TWD | -42.168% |
TaiRx, Inc. | -208.64 Million TWD | -56.012% |
CHO Pharma, Inc. | -277.73 Million TWD | -17.204% |
EirGenix Inc. | -664.4 Million TWD | 51.007% |
BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 540.454% |
Sunny Pharmtech Inc. | 69.14 Million TWD | 570.782% |
Lin BioScience, Inc. | -1.07 Billion TWD | 69.618% |
BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | -187.795% |
Feng Chi Biotech Corp. | 34.83 Million TWD | 1034.362% |
Bio Preventive Medicine Corp. | -62.34 Million TWD | -422.149% |
Lukas Biomedical Inc. | -26.3 Million TWD | -1137.692% |
RBC Bioscience Corporation | 36.54 Million TWD | 990.67% |
BiOptic Inc. | 65.03 Million TWD | 600.497% |
BRIM Biotechnology, Inc. | -682.46 Million TWD | 52.303% |
Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -886.224% |
Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -492.758% |
Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 175.08% |
Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -603.903% |
SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -1736.359% |
Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -214.156% |
Neith Corporation | -33.61 Million TWD | -868.5% |
Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -306.525% |
NaviFUS Corp. | -55.79 Million TWD | -483.409% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -1861.158% |
Sinew Pharma Inc. | -163.63 Million TWD | -98.931% |
Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -429.289% |
Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 269.184% |
Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | -43.601% |
Medigen Biotechnology Corp. | -1.04 Billion TWD | 68.839% |
3D Global Biotech Inc. | -35.84 Million TWD | -808.087% |
Pharmosa Biopharm Inc. | 29.13 Million TWD | 1217.449% |
Intech Biopharm Corporation | -219.58 Million TWD | -48.24% |
Oneness Biotech Co., Ltd. | -674.22 Million TWD | 51.721% |
Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -624.151% |
TWi Biotechnology, Inc. | -160.85 Million TWD | -102.362% |
Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 149.657% |
TCI GENE Inc. | 25.98 Million TWD | 1352.889% |
MegaPro Biomedical Co., Ltd | -110.63 Million TWD | -194.214% |
Senhwa Biosciences, Inc. | -283.78 Million TWD | -14.704% |
Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | -123.0% |
NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 2450.274% |
PharmaEngine, Inc. | 347.3 Million TWD | 193.725% |
Savior Lifetec Corporation | 219.6 Million TWD | 248.227% |
TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 288.999% |
OBI Pharma, Inc. | -855.08 Million TWD | 61.932% |
Meribank Biotech Co., Ltd | -92.56 Million TWD | -251.666% |
Acepodia, Inc. | -764.51 Million TWD | 57.423% |
Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 29.25% |